Vés al contingut

A phase 3 randomized, double-blinded, placebo controlled multicenter trial with open label extesion to evaluate the efficacy, safety and tolerability of efgartigimod PH20

Obert
  • Codi protocol: ARGX-113-2306
  • Codi EudraCT: No aplica
  • Grup de recerca: Reumatologia
  • Servei: Reumatologia
  • Investigador/a principal:  Marsal Barril, Sara
  • Malaltia: Tumors
  • Fase: Fase III